| Tanner Louis King, PT, DPT | |
|
7872 Century Blvd, Chanhassen, MN 55317-8005 | |
| (952) 448-9081 | |
| (952) 448-9088 |
| Full Name | Tanner Louis King |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 7872 Century Blvd, Chanhassen, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245951631 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 12816 (Minnesota) | Primary |
| Provider Name | Osr Physical Therapy Limited Partnership |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1336625326 PECOS PAC ID: 6103176540 Enrollment ID: O20180906001332 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 2, a Phase IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non Responders (INR) after at least 12 months of highly active anti-retroviral therapy (HAART).
Medivir (STO:MVIRB) has deepened its presence, and expanded its commercial interest, in the therapeutic area of bone diseases by selecting a further candidate drug that targets the protease cathepsin K, a recognized drug target in this area. This builds on Medivir's existing interest in bone related disorders which includes already one candidate drug and positive phase I experience from MIV-701.
Census Bureau data show that the share of immigrant-headed households with children using at least one welfare program continues to be very high.
Immunotherapy, which has achieved remarkable results in late-stage lung cancer patients, can also hold great hope for newly diagnosed patients, cutting the deadly disease off before it has the chance to take hold and offering a potential cure, according to a new Mount Sinai study published today in Cell.
For cardiovascular health to improve in the general population, healthcare systems will need to collect and assess treatment data, establish collaboration between researchers and healthcare professionals, and evolve patient care in real-time based on those data.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tanner Louis King, PT, DPT 7872 Century Blvd, Chanhassen, MN 55317-8005 Ph: (952) 448-9081 | Tanner Louis King, PT, DPT 7872 Century Blvd, Chanhassen, MN 55317-8005 Ph: (952) 448-9081 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 2, a Phase IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non Responders (INR) after at least 12 months of highly active anti-retroviral therapy (HAART).
Medivir (STO:MVIRB) has deepened its presence, and expanded its commercial interest, in the therapeutic area of bone diseases by selecting a further candidate drug that targets the protease cathepsin K, a recognized drug target in this area. This builds on Medivir's existing interest in bone related disorders which includes already one candidate drug and positive phase I experience from MIV-701.
Census Bureau data show that the share of immigrant-headed households with children using at least one welfare program continues to be very high.
Immunotherapy, which has achieved remarkable results in late-stage lung cancer patients, can also hold great hope for newly diagnosed patients, cutting the deadly disease off before it has the chance to take hold and offering a potential cure, according to a new Mount Sinai study published today in Cell.
For cardiovascular health to improve in the general population, healthcare systems will need to collect and assess treatment data, establish collaboration between researchers and healthcare professionals, and evolve patient care in real-time based on those data.
› Verified 2 days ago
Sierra N Wells, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2665 W 78th St, Chanhassen, MN 55317 Phone: 877-609-0123 | |
Jill M Lawrence, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2665 W 78th St, Chanhassen, MN 55317 Phone: 952-835-4512 Fax: 888-425-0398 | |
Patricia Kathleen Oys, P.T. , DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 300 Lake Dr E, Chanhassen, MN 55317 Phone: 952-993-4300 | |
Ellen Johnson, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 7872 Century Boulevand, Chanhassen, MN 55317 Phone: 952-448-9081 | |
Jessie Nicole Stevens, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7872 Century Blvd, Chanhassen, MN 55317 Phone: 952-448-9081 | |
Erik Thomas Krueger, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2665 W 78th St, Chanhassen, MN 55317 Phone: 952-835-4512 Fax: 888-425-0398 |